Racialized Economic Segregation Linked to Advanced Cancer Diagnosis

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 1, 2025.

via HealthDay

FRIDAY, Aug. 1, 2025 -- People living in racially and economically segregated neighborhoods are more likely to be diagnosed with advanced-stage breast and cervical cancer, according to a study published online July 24 in the Journal of the National Cancer Institute.

Qinran Liu, Ph.D., M.P.H., from the American Cancer Society in Atlanta, and colleagues examined the association between neighborhood-level segregation, measured by the neighborhood-Index of Concentration at Extremes, and stage at diagnosis for three screenable cancers in New York City. A total of 98,449 incident cases (58,970 breast, 4,790 cervical, and 34,689 colorectal) were analyzed using data from 2008 to 2019 from the New York State Cancer Registry.

The researchers found that compared with the most affluent and/or most non-Hispanic White-concentrated areas, the most deprived and/or non-Hispanic Black-concentrated areas had significantly higher advanced-to-localized stage incidence rate ratios for breast and cervical cancer. No association was seen for Hispanic concentration alone with disparities, but when combined with economic deprivation, disparities were seen in breast and cervical cancer. Increasing incidence rate ratios were seen for all racialized economic-segregation measures, with higher segregation for both cancers. For colorectal cancer, there were no disparities.

"Our findings have direct implications for cancer prevention and early detection efforts by identifying neighborhoods with the greatest disparities in stage at diagnosis," Liu said in a statement

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords